ASTRO-LAB group2020-12-172020-12-172020-03ASTRO-LAB group 2020, 'Effects of short- and long-acting beta-agonists on asthma exacerbations : a prospective cohort', Annals of Allergy, Asthma, and Immunology, vol. 124, no. 3, pp. 254-260. https://doi.org/10.1016/j.anai.2019.12.0121081-1206https://hdl.handle.net/2164/15537Funding Sources: The study was funded by the European Commission through the Seventh Framework Program (FP7-Grant Agreement n° 282 593) and gathered 7 partners in a consortium: Claude Bernard Lyon 1 University, University of Nottingham, Kappa Santé SAS, IMS Health, University of Amsterdam, Consortio Mar Parc de Salut de Barcelona and Lyon Ingénierie Projets. The study has been registered in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Registry under reference number ENCEPP/SDPP/3099.7851785engADDING SALMETEROLADHERENCECOMBINATIONCHILDRENRISKR MedicinePulmonary and Respiratory MedicineImmunology and AllergyImmunologyREffects of short- and long-acting beta-agonists on asthma exacerbations : a prospective cohortJournal article10.1016/j.anai.2019.12.012http://www.scopus.com/inward/record.url?scp=85077385674&partnerID=8YFLogxK1243